The Allstate Corporation
NYSE:ALLInsurance - Property & Casualty
-$2.30 today
- Market cap
- $65.97B
- Beta
- 0.19
- P/E (TTM)
- 4.7
- EPS (TTM)
- $46.82
- Dividend yield
- 1.90%
Volume 1.38M
Average 1.52M
ALL Interest Expense
Cost of servicing the company's debt during the period.
The Allstate CorporationNYSE: ALL
Interest Expense · Q2 FY2026 · quarter ended Jun 2026
Interest expense declines year over year
Q2 FY2026 interest expense of $96M fell 4.0% year over year, behind the -3.0% change in trailing-twelve-month interest expense. Sequentially, it fell 2.0% from the prior quarter. Over 3 fiscal years it compounded at +6.0% a year.
Context
- Interest expense amounted to 0.6% of revenue in FY2025, unchanged from a year earlier.
- Interest expense increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -4.0% toward the trailing-twelve-month pace of -3.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 399M USD
- Year-over-year change
- -0.3%
- 4-year CAGR
- +4.9%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 399M | -0.3% |
| FY2024 | 2024-12-31 | 400M | +5.5% |
| FY2023 | 2023-12-31 | 379M | +13.1% |
| FY2022 | 2022-12-31 | 335M | +1.5% |
| FY2021 | 2021-12-31 | 330M | — |
Interest Expense vs competitors
How ALL compares with its peers on the latest reported figures
- ALL's LTM Jun 2026 interest expense of $393M is the 3rd highest of the 11 companies compared; the peer median is $93.42M.
- Its year-over-year change of -3.0% is the lowest of 11, against a peer median of +13.2%.
- Interest expense amounts to 0.6% of revenue for ALL, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $807M | +7.9% | +10.3% | 1.3% | |
| LTM Sep 2026 | $463M | +13.8% | +6.6% | 0.9% | |
| LTM Jun 2026 | $393M | -3.0% | +6.0% | 0.6% | |
| LTM Sep 2026 | $314M | +12.6% | +4.4% | 0.3% | |
| LTM Sep 2026 | $199M | -0.5% | -2.2% | 0.7% | |
| LTM Sep 2026 | $134M | +2.3% | +6.4% | 0.9% | |
| LTM Sep 2026 | $52.83M | +21.9% | +19.6% | 1.0% | |
| LTM Sep 2026 | $52M | -1.9% | +0.0% | 0.4% | |
| LTM Sep 2026 | $45.4M | +22.0% | +8.2% | 0.7% | |
| LTM Sep 2026 | $12.3M | +122.0% | -12.7% | 0.6% | |
| LTM Mar 2026 | $2.04M | +317.1% | +42.9% | 0.2% | |
| Peer median (excluding ALL) | $93.42M | +13.2% | +6.5% | 0.7% | |
Competitors are the stored peer set for ALL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 48.68B | 50.62B | 56.59B | 63.52B | 66.46B |
| Cost of Revenue | 36.65B | 44.94B | 49.42B | 49.02B | 44.37B |
| Gross Profit | 12.03B | 5.68B | 7.17B | 14.5B | 22.09B |
| Gross Margin | 24.7% | 11.2% | 12.7% | 22.8% | 33.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | (644M) | 116M | 9M | (37M) | (30M) |
| Operating Expenses | 5.57B | 7.51B | 7.52B | 8.74B | 8.93B |
| Depreciation & Amortization | 1.09B | 847M | 704M | 555M | 482M |
| EBITDA | 7.88B | (648M) | 735M | 6.72B | 14.04B |
| EBITDA Margin | 16.2% | -1.3% | 1.3% | 10.6% | 21.1% |
| Operating Income | 6.47B | (1.83B) | (348M) | 5.76B | 13.16B |
| Operating Margin | 13.3% | -3.6% | -0.6% | 9.1% | 19.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 330M | 335M | 379M | 400M | 399M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 6.47B | (1.83B) | (348M) | 5.76B | 13.16B |
| Pre-Tax Margin | 13.3% | -3.6% | -0.6% | 9.1% | 19.8% |
| Income Tax Expense | 1.29B | (488M) | (135M) | 1.16B | 2.89B |
| Net Income | 1.61B | (1.29B) | (188M) | 4.67B | 10.28B |
| Net Margin | 3.3% | -2.5% | -0.3% | 7.3% | 15.5% |
| EPS (Basic) | 5.04 | (5.03) | (1.20) | 17.22 | 38.68 |
| EPS (Diluted) | 4.96 | (5.03) | (1.20) | 16.99 | 38.19 |
| Weighted Avg Shares | 294.8M | 271.2M | 262.5M | 264.3M | 261.3M |
| Weighted Avg Shares (Diluted) | 299.1M | 271.2M | 262.5M | 267.8M | 264.7M |
The Allstate Corporation
NYSE:ALL
Intrinsic Alpha fair value
Locked
Current Price
$266.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.